Scinai Immunotherapeutics Ltd.

NasdaqCM:SCNI Stock Report

Market Cap: US$3.0m

Scinai Immunotherapeutics Ltd. Company Information

Scinai Immunotherapeutics Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Scinai Immunotherapeutics Ltd.
  • Ticker: SCNI
  • Exchange: NasdaqCM
  • Founded: 2003
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$2.969m
  • Shares Outstanding: 838.58k
  • Website: https://www.scinai.com

Number of Employees

Location

  • Scinai Immunotherapeutics Ltd.
  • Jerusalem BioPark
  • 2nd floor
  • Jerusalem
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SCNINasdaqCM (Nasdaq Capital Market)YesSPON ADS EACH REP 400 ORD SHS(POST SPLT)USUSDMay 2015
2F5DB (Deutsche Boerse AG)YesSPON ADS EACH REP 400 ORD SHS(POST SPLT)DEEURMay 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 19:41
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.